ClinicalTrials.gg
Enrolling by invitationNCT07578389BREATHWATCHUpdated May 11, 2026

Validation of Respiratory Rate Measurement Accuracy Using a Smartwatch

An interventional study of Respiratory rate monitoring using wearable device in Respiratory Rate Monitoring, sponsored by Czech Technical University in Prague. Enrolling by invitation at 1 site in Czechia. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-11.

Sponsored by Czech Technical University in Prague · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Dec 2025, registered May 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This prospective study evaluates the accuracy of commercial wearable devices by comparing their respiratory rate measurements against clinical standards like spirometers and ECGs in healthy adults. The goal is to determine if these devices are reliable enough for non-invasive respiratory monitoring in both everyday and medical environments.

Read the detailed description

This prospective interventional study evaluates the accuracy of respiratory rate measurement using commercially available wearable devices. Respiratory rate measured by wearable devices will be compared with reference measurements obtained from a spirometer and ECG.

Healthy adult volunteers will participate in a short experimental protocol including different breathing conditions. Respiratory rate will be recorded simultaneously by wearable devices and reference monitoring systems.

The aim of the study is to determine whether wearable devices can reliably measure respiratory rate and to assess their potential for non-invasive respiratory monitoring in everyday and clinical settings.

02

Conditions studied

  • Respiratory Rate Monitoring

Keywords

  • Respiratory rate
  • Wearable devices
  • Respiratory monitoring
  • Physiological monitoring
  • Wearable sensors
  • Non-invasive monitoring
  • Validation study
03

In context

Lead sponsor

Czech Technical University in Prague is the lead sponsor of 36 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy adults aged 18 years or older
  • Ability to understand the study procedures and provide
  • Willingness to participate in the experimental measurement protocol

Exclusion criteria

Exclusion Criteria:

  • Known respiratory diseases (e.g., asthma, )
  • Known cardiovascular diseases or conditions limiting safe participation
  • Acute illness or infection at the time of measurement
  • Neurological or musculoskeletal conditions affecting breathing or the ability to participate in the measurement protocol
  • Pregnancy
  • Use of alcohol or other substances affecting physiological measurements at the time of the experiment
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Respiratory rate monitoring with wearable device and reference monitoring systems

    Measurement of respiratory rate using a wearable device and reference monitoring systems in healthy adult volunteers during a short experimental protocol under different breathing conditions.

    Other: Respiratory rate monitoring using wearable device

Interventions

  • OtherRespiratory rate monitoring using wearable device

    Respiratory rate monitoring using a wearable device during a controlled experimental protocol in healthy volunteers. Measurements obtained from the wearable device are compared with reference respiratory measurements obtained using spirometry and a clinical vital signs monitor.

06

What researchers measure

Primary outcomes

  1. Accuracy of respiratory rate measurement using a wearable device

    Agreement between respiratory rate measured by the wearable device and reference measurements obtained from spirometry and a clinical vital signs monitor in healthy volunteers.

    Time frame: During the experimental measurement session (approximately 20 minutes)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The measured data will be shared publicly in the data repository on web page: https://ventilation.fbmi.cvut.cz/data/

Access criteria: Unlimited from the time of processing complete measured data

Data sharing details ↗ · ventilation.fbmi.cvut.cz

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07578389
Lead sponsor
Czech Technical University in Prague
Responsible party
Sponsor
First posted
May 11, 2026
Start date
Dec 13, 2025
Primary completion
Dec 30, 2026 (estimated)
Completion
May 30, 2027 (estimated)
Last update
May 11, 2026

Study contacts

Simon Walzel, PhD
principal investigator · Czech Technical University in Prague

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion